WINDWARD BIO GROUP AG (WWB) shareholders
WWBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$22.64−3.12 (-12.11%)
Close on Nov 18, 2026Market cap –P/E –Yield –
Ownership
Who owns Windward Bio's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
4 buys · 0 sales
Net bought $69.75M
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Luca Santarelli | Chief Executive Officer, Director | 4,578,110 | Nov 16, 2026 |
| Scott Applebaum | Chief Legal & Corp Dev Officer | 960,966 | Nov 16, 2026 |
| Claudia D'Augusta | Chief Financial Officer | 927,760 | Nov 16, 2026 |
| Kevin Andrew Harris | Chief Operating Officer | 960,966 | Nov 16, 2026 |
| Omar Khwaja | Chief Medical Officer | 642,136 | Nov 16, 2026 |
| Advisors Llc Orbimed | Director, 10% owner | 7,097,483 | Nov 18, 2026 |
| Capital GP IX LLC OrbiMed | Director, 10% owner | – | Nov 18, 2026 |
| Otello Stampacchia | Director | 5,338,520 | Nov 18, 2026 |
| David P. Bonita | Director, 10% owner | 7,097,483 | Nov 18, 2026 |
| Iqbal Rasool Mufti | Director | – | Nov 16, 2026 |
| Sandip Kapadia | Director | 100,000 | Nov 16, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Otello Stampacchia Director | Nov 16, 2026 | Conversion | +531,634 | – | – | 2,669,260 |
| Otello Stampacchia Director | Nov 16, 2026 | Conversion | +531,632 | – | – | 2,669,260 |
| Otello Stampacchia Director | Nov 16, 2026 | Conversion | +1,262,626 | – | – | 2,137,626 |
| Otello Stampacchia Director | Nov 16, 2026 | Conversion | +1,262,628 | – | – | 2,137,628 |
| Otello Stampacchia Director | Nov 16, 2026 | Buy | +875,000 | $17.00 | $14.88M | 875,000 |
| Otello Stampacchia Director | Nov 16, 2026 | Buy | +875,000 | $17.00 | $14.88M | 875,000 |
| David P. Bonita Director, 10% owner | Nov 16, 2026 | Tax withholding | −232 | $17.00 | $3.94K | 7,097,483 |
| David P. Bonita Director, 10% owner | Nov 16, 2026 | Option exercise | +216,668 | $0.02 | $4.33K | 7,097,715 |
| David P. Bonita Director, 10% owner | Nov 16, 2026 | Conversion | +1,611,008 | – | – | 6,881,047 |
| David P. Bonita Director, 10% owner | Nov 16, 2026 | Conversion | +3,561,936 | – | – | 5,270,039 |
| David P. Bonita Director, 10% owner | Nov 16, 2026 | Buy | +1,176,471 | $17.00 | $20.00M | 1,708,103 |
| Advisors Llc Orbimed Director, 10% owner | Nov 16, 2026 | Tax withholding | −232 | $17.00 | $3.94K | 7,097,483 |
| Advisors Llc Orbimed Director, 10% owner | Nov 16, 2026 | Option exercise | +216,668 | $0.02 | $4.33K | 7,097,715 |
| Advisors Llc Orbimed Director, 10% owner | Nov 16, 2026 | Conversion | +1,611,008 | – | – | 6,881,047 |
| Advisors Llc Orbimed Director, 10% owner | Nov 16, 2026 | Conversion | +3,561,936 | – | – | 5,270,039 |
| Advisors Llc Orbimed Director, 10% owner | Nov 16, 2026 | Buy | +1,176,471 | $17.00 | $20.00M | 1,708,103 |
| Kevin Andrew Harris Chief Operating Officer | Nov 16, 2026 | Award | +33,206 | – | – | 960,966 |
| Sandip Kapadia Director | Nov 16, 2026 | Award | +100,000 | – | – | 100,000 |
| Scott Applebaum Chief Legal & Corp Dev Officer | Nov 16, 2026 | Award | +33,206 | – | – | 960,966 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
See a number that looks wrong?